Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2014-08-25 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
重大事项继续停牌公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the continued suspension of its stock trading due to ongoing major matters related to refinancing. It references previous suspension announcements and states that the stock will remain suspended until further notice. The document does not contain financial statements, detailed financial data, or a full report. It is an update on a capital/financing event (refinancing) and the stock suspension related to it. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is CAP with high confidence.
2014-08-25 Chinese
2014年半年度财务报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "嘉事堂药业股份有限公司 2014 年半年度财务报告" which translates to "Jia Shi Tang Pharmaceutical Co., Ltd. 2014 Semi-Annual Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity. The report is for a half-year period (semi-annual) in 2014 and is unaudited as indicated. The length is substantial (15,000 characters), and the content includes actual financial data and analysis, not just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. H1 2014
2014-08-20 Chinese
独立董事对公司关联方资金占用和对外担保情况专项说明和独立意见
Audit Report / Information Classification · 95% confidence The document is a statement from independent directors regarding the company's related party fund occupation and external guarantees for the first half of 2014. It provides an independent opinion confirming no violations or irregularities in these areas during the reporting period. The document is short (793 characters) and focuses on compliance and independent opinion rather than detailed financial data or full audit results. It does not contain comprehensive financial statements or audit details, so it is not an Annual Report (10-K) or Audit Report (AR). It is a specialized statement related to audit or compliance matters, fitting the category of Audit Report / Information (AR). H1 2014
2014-08-20 Chinese
第四届监事会第九次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the supervisory board meeting resolution approving the company's 2014 semi-annual report. It states that the supervisory board reviewed and approved the 2014 half-year report, confirming its compliance and accuracy. The document references the actual 2014 half-year report published elsewhere (with announcement numbers 2014-030 and 2014-031) and does not contain the financial data itself. The document length is short (808 characters) and serves as a formal announcement of the meeting resolution rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement related to the supervisory board's approval of the interim report, not the interim report itself (IR).
2014-08-20 Chinese
第四届董事会第十五次会议决议的公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions from the 15th meeting of the 4th Board of Directors of 嘉事堂药业股份有限公司. It states that the board approved the 2014 semi-annual report but does not contain the report itself. It references the actual semi-annual report published elsewhere with specific announcement numbers and publication dates. The document is short (748 characters) and serves to announce the board meeting decisions and the approval of the interim report, not the report itself. Therefore, it fits the category of Board/Management Information (MANG) as it relates to board meeting resolutions and approvals.
2014-08-20 Chinese
2014年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2014 半年度报告摘要' which translates to '2014 Semi-Annual Report Summary'. It contains detailed financial data for the half-year period, including revenue, net profit, earnings per share, and asset information. It also includes management discussion and analysis, changes in consolidated subsidiaries, and other substantive financial and operational details. The length of the document (7,217 characters) and the presence of comprehensive financial data and analysis confirm it is a financial report rather than a brief announcement or certification. The document corresponds to an Interim / Quarterly Report as it covers a period shorter than a full fiscal year (half-year). Therefore, the appropriate classification is 'IR' (Interim / Quarterly Report). H1 2014
2014-08-20 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.